Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from biotech

Undervalued Biotech Stocks Ready for a Breakout

The biotech industry's future appears bright due to advancements in biochemical and pharma technologies, AI integration, rising targeted treatments, and increased R&D spending driving breakthroughs. Therefore, it could be wise to invest in undervalued biotech stocks such as Harmony Biosciences Holdings (HRMY), United Therapeutics (UTHR), and BioMarin Pharmaceutical (BMRN). Read…

StockNews.com

3 Oncology Stocks With Major Upside

With the rising prevalence of chronic diseases, increasing cell and gene therapies, and rising tech adoption in the biotech industry, the oncology market is booming. Amid this backdrop, investors could consider quality biotech stocks Pyxis Oncology (PYXS), Immatics (IMTX), and Jazz Pharmaceuticals (JAZZ), having significant upside potential. Continue reading.

StockNews.com

3 High-Potential Biotech Stocks Under $10

The biotech industry is witnessing rapid growth owing to its increasing demand and the inclusion of technological advancements. In this wake, investors could consider adding pocket-friendly biotech stocks Fulcrum Therapeutics (FULC), BioCryst Pharmaceuticals (BCRX), and Precision BioSciences (DTIL) to their portfolio. Continue to read….

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Biotech Stocks With Anticipated Strong Earnings Reports

With highly effective drugs and treatment options, chronic disease prevalence, and adoption of technology, the biotech market is thriving. Hence, fundamentally solid biotech stocks Illumina (ILMN), Amgen (AMGN), and Entrada Therapeutics (TRDA) could be ideal with anticipated strong earnings reports. Read more.

StockNews.com

3 Biotech Stocks to Buy Before Their Earnings Announcements

Buoyed by encouraging clinical trial results and new advancements, the biotech industry is on a strong upward trajectory. Given the sector’s growing potential, I have highlighted three biotech stocks, Exelixis (EXEL), Gilead Sciences (GILD), and Halozyme Therapeutics (HALO), to consider before their second-quarter earnings report. Read on….

StockNews.com

2 Hot Biotech Stocks to Watch This Month

The biotech industry shows promise due to advanced trends like AI and VR simulations, a growing global patient population, and increased R&D spending in 2024. Therefore, let's analyze the fundamentals of biotech stocks, Innoviva (INVA) and Entrada Therapeutics (TRDA) to understand why they are worth watching this month. Read more.

StockNews.com

3 Biotech Stocks With Revolutionary Pipelines to Buy Today

The biotech industry is experiencing rapid growth owing to new drug innovations and advancements in healthcare. To capitalize on the industry's expansion, it could be wise to invest in solid biotech stocks, Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), and Gilead Sciences (GILD), which have revolutionary pipelines. Read on….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

3 High-Risk, High-Reward Biotech Stocks

With ever-expanding operations, rapid technological innovation, and adoption of AI, the biotechnology industry is poised for solid long-term growth. Thus, investors could consider buying high risk, but rewarding biotech stocks United Therapeutics (UTHR), Entrada Therapeutics (TRDA), and Exelixis (EXEL). Continue reading.

StockNews.com

3 Biopharma Stocks to Buy for Long-Term Growth

With the rising investment in personalized medicine research and development and growing clinical trials, the biopharma industry’s prospects appear promising. Hence, quality biotech stocks, Alnylam Pharmaceuticals (ALNY), Illumina (ILMN), and Gilead Sciences (GILD) with long-term growth might be solid buys. Read more….

StockNews.com

3 Biotech Stocks With Sky-High Price Targets

The biotech sector is primed for growth, fueled by numerous advancements in genetic engineering and rising investment in research and development of personalized medicine. Hence, quality biotech stocks, BioMarin Pharmaceutical (BMRN), Alnylam Pharmaceuticals (ALNY), and Corcept Therapeutics (CORT) with sky-high price targets might be solid buys. Read more….

StockNews.com

3 Popular Biotech Stocks Offering Solid June Returns

The biotech industry is poised for significant growth due to the rising orphan drug formulations and the surging popularity of plant-based products. Hence, quality biotech stocks, Exelixis (EXEL), Vertex Pharmaceuticals (VRTX), and Jazz Pharmaceuticals (JAZZ) could be ideal investments for solid returns. Read more….

StockNews.com

3 Biotech Stocks for Investing in the Future

The biotech sector is primed for robust expansion fueled by the growing needs for personalized medicines and favorable government initiatives. Amid this backdrop, investors could consider buying biotech stocks Esperion Therapeutics (ESPR), Corcept Therapeutics (CORT), and Shionogi (SGIOY). Keep reading.

StockNews.com

3 Biotech Stocks With Potential Breakthroughs Emerging

The biotech industry's future is promising, driven by advanced technologies like AI and VR, the rising popularity of personalized treatments, and increased R&D spending. Let's analyze the investment prospects of biotech stocks Amgen (AMGN), United Therapeutics (UTHR), and Gilead Sciences (GILD) as potential breakthroughs emerge. Read more.

StockNews.com

4 Biotech Stocks Ready to Surge in June

The biotech industry's prospects look promising due to the use of advanced technologies like AI and VR for research, the growing popularity of tailored treatments and biotech devices, a rise in chronic diseases, and increased R&D spending. Therefore, investors could consider buying biotech stocks Innoviva (INVA), Halozyme Therapeutics (HALO), Jazz…

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

3 Biotech Stocks Under $20 Worth Watching in June

The biotech industry’s long-term expansion is fueled by increasing medical needs globally, favorable government support, and technological advances. Given the industry’s rosy outlook, quality biotech stocks Equillium (EQ), SIGA Technologies (SIGA), and Shionogi & Co. (SGIOY) trading under $20 could be worth watching in June. Keep reading….

StockNews.com

3 Value Biotech Stocks With Breakout Potential in 2024

Given growing healthcare spending, supportive government policies, and technological innovation, the biotechnology industry is poised for solid long-term growth. Thus, investors could consider buying quality biotech stocks Harmony Biosciences (HRMY), Esperion Therapeutics (ESPR), and Entrada Therapeutics (TRDA), which are trading at a discount. Read on….

StockNews.com

3 Biotech Stocks Poised for May Surges

The use of advanced technologies, growing demand for personalized medicines, and rising investments in R&D are boosting the biotech industry’s prospects. Given this backdrop, investors could consider buying quality biotech stocks: Amgen (AMGN), Jazz Pharmaceuticals (JAZZ), and ANI Pharmaceuticals (ANIP). Read on.

StockNews.com

3 A-Rated Biotech Stocks for Long-Term Investors

The future of the biotech industry appears bright, driven by extensive usage across healthcare and agriculture alongside rapid advancements in technology. Thus, top biotech stocks Entrada Therapeutics (TRDA), Exelixis (EXEL), and Gilead Sciences (GILD) could be solid buys for long-term investors. These stocks are rated A (Strong Buy) in our…

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

3 Biotech Stocks to Monitor for May Moves

The biotech industry is well poised to flourish, buoyed by its strong emphasis on technology-driven advancements to address complex medical challenges and government funding. Hence, quality biotech stocks Harmony Biosciences Holdings (HRMY), Illumina (ILMN), and Compugen (CGEN) could be ideal watchlist additions for May. Read more….

StockNews.com

3 Biotech Stocks to Consider Buying Right Away

The biotechnology industry is thriving, fueled by solid government support, rising healthcare spending worldwide, gene editing breakthroughs, and rapid AI adoption. Hence, fundamentally solid biotech stocks Shionogi (SGIOY), United Therapeutics (UTHR), and SIGA Technologies (SIGA) could be ideal buys for potential gains. Keep reading….

StockNews.com

Biotech Buyers Beware: 3 Stocks to Avoid

The biotech industry is flourishing due to groundbreaking developments in cell and gene therapies and the rapid adoption of new technologies. However, not all biotech stocks are positioned to capitalize on the industry tailwinds. Thus, investors must beware of fundamentally weak stocks: Alpine Immune (ALPN), Kura Oncology (KURA), and Blueprint…

StockNews.com

3 Biotech Stocks Heating up for May

The biotech industry is expected to grow rapidly due to rising medical needs globally, favorable government initiatives, and rapid AI adoption. Amid this backdrop, quality biotech stocks Royalty Pharma (RPRX), Anika Therapeutics (ANIK), and Innoviva (INVA) could be ideal investments this month. Read more….

StockNews.com

3 Biotech Stocks to Buy to Power Through April

The biotech sector is primed for growth, fueled by a surge in FDA approvals, anticipated M&A deals, and the integration of AI in drug discovery. So, fundamentally sound biotech stocks Theratechnologies (THTX), Harmony Biosciences (HRMY), and Shionogi & Co. (SGIOY) might be solid buys in this month. Keep reading.

StockNews.com

3 Biotech Stocks Paving the Way for Bullish Investment Gains

The biotech industry is rapidly expanding due to the popularity of personalized medicines and novel therapies, government initiatives, and technological adoption. Hence, quality biotech stocks Alnylam Pharmaceuticals (ALNY), Dynavax Technologies (DVAX), and Innoviva (INVA) could pave the way for substantial gains. Read more….

StockNews.com

3 Biotech Stocks to Watch for Lucrative Gains

The biotech sector’s robust long-term growth is driven by strong government support, the rising foothold of personalized medicine, the growing number of orphan drug formulations, and rapid AI adoption. Hence, biotech stocks G1 Therapeutics (GTHX), Vanda Pharmaceuticals (VNDA), and Royalty Pharma (RPRX) could be ideal additions to your watchlist. Keep…

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Vertex Pharmaceuticals Incorporated

65 stories

CORT

55 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.